Displaying items by tag: department of medicine

In a new trial funded through UAB’s urgent COVID-19 research program, investigators are comparing the widely available steroid methylprednisolone with dexamethasone, which lowered risk of dying by one-third in a U.K. trial this summer.
A drug that inhibits the protease plasmin is hypothesized to reduce the infectivity and virulence of the virus, as measured by reduced need for hospitalization within a week.
Drs. Vickers and Pisu will use a $3 million, five-year National Institute on Minority Health and Health Disparities grant to study barriers that may exist for GI cancer patients to access quality cancer surgery in Alabama and Mississippi.
New recommendations for sexual behavior counseling suggest that shorter, more frequent sessions in a clinical setting can be valuable. 
A long time UAB rheumatologist has been named director of division in the UAB School of Medicine.   
UAB scientist Jessy Deshane is one of five researchers to receive a specialized grant from NanoString Technologies, which will allow her to evaluate immune response in 3D non-small-cell lung cancer models.
A study conducted by UAB investigators shows that nearly a third of non-Hispanic Black young adults nationwide have hypertension, and the control of high blood pressure in all young adults is only 10 percent.
A $75,000 gift from the Mike & Gillian Goodrich Foundation to support cancer awareness and COVID-19 response in Alabama’s Back Belt region was given to the O’Neal Comprehensive Cancer Center at UAB.
Three UAB doctors and professors share five ways the medical community can work to address the needs of underrepresented populations as we work to understand COVID-19.
In light of COVID-19, changes to protect patient and employee health have been made for UAB Medicine clinic and hospital visits.
Page 18 of 37